We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00086320
Recruitment Status : Completed
First Posted : July 1, 2004
Last Update Posted : June 8, 2011
Information provided by: